 - Stage III-IVB head and neck squamous cell carcinoma HNSCC or nasopharyngeal cancer WHO type I, II or III,, previously untreated. Patients with stage II hypopharynx HNSCC will also be eligible. Pathology must be confirmed at MSKCC 